Apnimed Announces Strategic Monetization of Shionogi-Apnimed Sleep Science (SASS) Joint Venture Stake for $150M and Royalties, Strengthening Focus on its Wholly-Owned OSA Program, AD109
Slide Raises $70 Million Series B Led by General Catalyst to Expand Its Business Continuity and Disaster Recovery (BCDR) Platform for Managed Service Providers